Skip to content

Comparative efficacy of two different approaches of Subclavian vein cannulation under ultrasound guidance

Comparative efficacy of Supraclavicular versus Infraclavicular approach of Subclavian vein cannulation under ultrasound guidance: A randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/013751
Enrollment
90
Registered
2018-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Posted for elective or emergency surgeries requiring Central venous catheter insertion

Interventions

Intervention1: Supraclavicular subclavian vein cannulation: Supraclavicular subclavian vein cannulation using ultrasound in long axis till first blood is visible in the hub of needle (usually less tha

Sponsors

AIIMS Rishikesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are undergoing elective or emergency surgeries requiring central venous catheter insertion

Exclusion criteria

Exclusion criteria: Refusal to consent for study, bleeding disorders, uncontrolled hypertension, severe COPD, vascular malformations, severe cardiac disease

Design outcomes

Primary

MeasureTime frame
To compare the puncture time between infraclavicular and supraclavicular approaches under USG guidanceTimepoint: time measured from start of procedure to the first appearance of blood in the syringe

Secondary

MeasureTime frame
To assess the number of attempts required for each approachTimepoint: Number of times needle is withdrawn and reinserted;To assess incidence of complications such as pneumothorax and arterial punctureTimepoint: From skin puncture to end of surgery

Countries

India

Contacts

Public ContactT Mageshwaran

AIIMS

deepak10.4u@gmail.com8077447687

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026